Planitax CEO to Moderate Panel Discussion at Pharma/Biotech Tax Congress

ALAMEDA, Calif.--(BUSINESS WIRE)--Planitax, Inc., the leading provider of tax information management solutions for corporate tax departments, today announced that its chief executive officer, Greg Prow, will moderate a panel discussion at the 3rd Annual Pharmaceutical/Biotech Tax and Transfer Pricing Congress on November 17, 2008, in Philadelphia. This Congress addresses the tax and transfer pricing issues distinctive to the life sciences industry to update attendees about the latest tax rulings, available tax credits for R&D companies and legislative developments impacting state, federal and global taxation.
MORE ON THIS TOPIC